IL166343A0 - Igg fc/hiv-gp 120/c3d fusion protein - Google Patents

Igg fc/hiv-gp 120/c3d fusion protein

Info

Publication number: IL166343A0
Authority: IL; Israel
Prior art keywords: hiv; igg; fusion protein; fusion; protein
Prior art date: 2002-07-23

Application number

IL16634305A

Other languages

English (en)

Original Assignee

Univ Duke

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-23

Filing date

2005-01-17

Publication date

2006-01-16

2005-01-17 Application filed by Univ Duke filed Critical Univ Duke

2006-01-16 Publication of IL166343A0 publication Critical patent/IL166343A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL16634305A 2002-07-23 2005-01-17 Igg fc/hiv-gp 120/c3d fusion protein IL166343A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39760502P	2002-07-23	2002-07-23
PCT/US2003/022917 WO2004009785A2 (fr)	2002-07-23	2003-07-23	Proteine de fusion igg fc/hiv-gp120/c3d

Publications (1)

Publication Number	Publication Date
IL166343A0 true IL166343A0 (en)	2006-01-16

Family

ID=30771086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16634305A IL166343A0 (en)	2002-07-23	2005-01-17	Igg fc/hiv-gp 120/c3d fusion protein

Country Status (13)

Country	Link
US (1)	US20060014148A1 (fr)
EP (2)	EP1523492A4 (fr)
JP (2)	JP2006509496A (fr)
KR (1)	KR20050036960A (fr)
CN (1)	CN100366631C (fr)
AU (1)	AU2003256671B2 (fr)
BR (1)	BR0312808A (fr)
CA (1)	CA2493706A1 (fr)
IL (1)	IL166343A0 (fr)
MX (1)	MXPA05000874A (fr)
NZ (1)	NZ537345A (fr)
WO (1)	WO2004009785A2 (fr)
ZA (1)	ZA200410324B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004503205A (ja)	2000-02-04	2004-02-05	デューク・ユニバーシティー	ヒト免疫不全ウイルスワクチン
JP2004511444A (ja)	2000-09-22	2004-04-15	デューク・ユニバーシティー	免疫原
US7033593B2 (en)	2000-09-22	2006-04-25	Duke University	Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
WO2003039470A2 (fr)	2001-11-07	2003-05-15	Duke University	Immunogene polyvalent
US7195768B2 (en)	2001-11-07	2007-03-27	Duke University	Polyvalent immunogen
US7172761B2 (en)	2001-11-07	2007-02-06	Duke University	Polyvalent immunogen
GB0614780D0 (en) *	2006-07-25	2006-09-06	Ucb Sa	Biological products
WO2009137632A2 (fr) *	2008-05-06	2009-11-12	Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Immunogène du vih et son procédé de fabrication et d'utilisation
WO2010045613A1 (fr) *	2008-10-16	2010-04-22	New York Blood Center	Vaccins oligomères contre le vih liés à un stimulateur d'immunité
US9592287B2 (en)	2009-10-09	2017-03-14	New York Blood Center, Inc.	Immunopotentiator-linked oligomeric influenza immunogenic compositions
WO2011126576A2 (fr) *	2010-04-09	2011-10-13	Duke University	Signatures génétiques présentes dans la glycoprotéine d'enveloppe du vih-1
EP2578309B1 (fr)	2010-05-24	2017-12-13	Incorporated Administrative Agency National Agriculture And Food Research Organization	Procede de granulation
AU2012311238A1 (en) *	2011-09-23	2014-04-17	University Of Oslo	Vaccibodies targeted to cross-presenting dendritic cells
EP2706356A1 (fr) *	2012-09-06	2014-03-12	Laboratorios Del. Dr. Esteve, S.A.	Procédés d'identification d'anticorps neutralisant le VIH
JP6955487B2 (ja) *	2015-09-24	2021-10-27	アブビトロ，エルエルシー	Ｈｉｖ抗体組成物および使用方法
KR20230019227A (ko) *	2017-11-17	2023-02-07	그리폴스 다이어그노스틱 솔루션즈 인크.	신규한 포유동물 발현 인간 면역결핍 바이러스 외피 단백질 항원

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5225538A (en) *	1989-02-23	1993-07-06	Genentech, Inc.	Lymphocyte homing receptor/immunoglobulin fusion proteins
EP0699077B1 (fr) *	1993-05-07	2001-10-31	Akzo Nobel N.V.	Complexes immunogenes de v.i.h.
JP2004511444A (ja)	2000-09-22	2004-04-15	デューク・ユニバーシティー	免疫原
WO2003039470A2 (fr)	2001-11-07	2003-05-15	Duke University	Immunogene polyvalent

2003
- 2003-07-23 EP EP03765923A patent/EP1523492A4/fr not_active Withdrawn
- 2003-07-23 NZ NZ537345A patent/NZ537345A/en not_active IP Right Cessation
- 2003-07-23 JP JP2004523297A patent/JP2006509496A/ja not_active Withdrawn
- 2003-07-23 US US10/518,523 patent/US20060014148A1/en not_active Abandoned
- 2003-07-23 WO PCT/US2003/022917 patent/WO2004009785A2/fr not_active Ceased
- 2003-07-23 CN CNB038171961A patent/CN100366631C/zh not_active Expired - Fee Related
- 2003-07-23 AU AU2003256671A patent/AU2003256671B2/en not_active Ceased
- 2003-07-23 EP EP10013160A patent/EP2374811A1/fr not_active Withdrawn
- 2003-07-23 CA CA002493706A patent/CA2493706A1/fr not_active Abandoned
- 2003-07-23 BR BR0312808-3A patent/BR0312808A/pt not_active IP Right Cessation
- 2003-07-23 KR KR1020057001219A patent/KR20050036960A/ko not_active Withdrawn
- 2003-07-23 MX MXPA05000874A patent/MXPA05000874A/es unknown
2004
- 2004-12-22 ZA ZA200410324A patent/ZA200410324B/en unknown
2005
- 2005-01-17 IL IL16634305A patent/IL166343A0/xx unknown
2009
- 2009-10-02 JP JP2009230429A patent/JP2010057490A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU2003256671A1 (en)	2004-02-09
CA2493706A1 (fr)	2004-01-29
EP1523492A2 (fr)	2005-04-20
US20060014148A1 (en)	2006-01-19
CN100366631C (zh)	2008-02-06
CN1668633A (zh)	2005-09-14
NZ537345A (en)	2007-12-21
KR20050036960A (ko)	2005-04-20
JP2006509496A (ja)	2006-03-23
ZA200410324B (en)	2006-07-26
MXPA05000874A (es)	2005-03-23
WO2004009785A2 (fr)	2004-01-29
JP2010057490A (ja)	2010-03-18
EP1523492A4 (fr)	2006-05-10
AU2003256671B2 (en)	2008-10-16
WO2004009785A3 (fr)	2004-08-05
EP2374811A1 (fr)	2011-10-12
BR0312808A (pt)	2005-04-19

Publication	Publication Date	Title
IL166751A0 (en)	2006-01-15	Modified transferin-antibody fusion proteins
AU2002364586A8 (en)	2003-07-30	Albumin fusion proteins
AU2002364587A8 (en)	2003-07-30	Albumin fusion proteins
PL362324A1 (en)	2004-10-18	Artificial fusion proteins with reduced immunogenicity
IL202255A0 (en)	2010-06-16	Binding domain-immunoglobulin fusion proteins
AU2003239365A8 (en)	2003-11-17	Recombinant glycosyltransferase fusion proteins
EP1448588A4 (fr)	2006-10-25	Anticorps et multimeres de proteines psma
AU2002307255A1 (en)	2002-10-28	Vegf fusion proteins
ZA200308589B (en)	2004-07-12	Recombinant fusion proteins and the trimers thereof.
IL166343A0 (en)	2006-01-16	Igg fc/hiv-gp 120/c3d fusion protein
AU2002332041A1 (en)	2003-04-22	Albumin fusion proteins
AU2003228364A8 (en)	2003-10-13	Field-assisted fusion bonding
AU2003253621A1 (en)	2003-12-31	Modified "s" antibodies
HUP0402496A3 (en)	2012-03-28	Growth hormone fusion protein
AU2002361390A8 (en)	2003-06-30	Anti-cd7 immunotoxin as fusion protein
GB9913437D0 (en)	1999-08-11	Fusion proteins
AU2002257088A1 (en)	2002-09-24	Immunoglobulin superfamily proteins
AU2002357891A8 (en)	2003-07-24	Dtat fusion toxin
EP1572092A3 (fr)	2005-10-20	Proteines interactives avec mk2
GB0200689D0 (en)	2002-02-27	Fusion proteins
AU2002231602A1 (en)	2002-08-28	Rank ligand-binding polypeptides
AU2002361963A1 (en)	2003-06-10	Fusion proteins containing tlp peptides
AU2003230516A1 (en)	2003-11-17	Fusion polypeptide, use thereof and methods employing it
AU2002360333A1 (en)	2003-05-12	Human angiomotin-like protein 1
HK1070388A (en)	2005-06-17	Fusion proteins